Investigation of Sacroiliac Fusion Treatment is a multicenter, prospective, randomized trial. Patients with the two conditions for which iFuse is indicated (degenerative sacroiliitis and sacroiliac joint disruption) are enrolled if they meet eligiblity all criteria and agree to participate in the study. Patients are randomized to either immediate iFuse treatment or an optimized program of non-surgical management (NSM).
For more information:
Overlake Medical Clinics Neurosurgery